Orange Book product · Brand (NDA)
SFROWASA
MESALAMINE
At a glance
Jun 20, 2008
Approved
Brand (NDA)
Application
AB
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 20, 2008
18 yr 3 mo ago
Today
Patent 7645801 expires
Listed drug substance patent expiration.
Jul 24, 2027
in 1 yr 1 mo
Pharmaceutical detail
Active ingredient
MESALAMINE
Strength
4GM/60ML
Dosage form
ENEMA
Route
RECTAL
TE code
AB
Application
NDA 019618
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2013DELZICOLBrand (NDA)
NDA 204412 · ABBVIE
- 2008APRISOBrand (NDA)
NDA 022301 · SALIX
- 2008ASACOL HDBrand (NDA)
NDA 021830 · ABBVIE
- 2007LIALDABrand (NDA)
NDA 022000 · TAKEDA PHARMS USA
- 2004CANASABrand (NDA)
NDA 021252 · ABBVIE
- 1993PENTASABrand (NDA)
NDA 020049 · TAKEDA PHARMS USA
- 1992ASACOLBrand (NDA)
NDA 019651 · APIL
- 1990ROWASABrand (NDA)
NDA 019919 · MEDA PHARMS
- 2026MESALAMINEGeneric (ANDA)
ANDA 220016 · KLM LABS PVT
- 2026MESALAMINEGeneric (ANDA)
ANDA 219997 · DIFGEN PHARMS
- 2025MESALAMINEGeneric (ANDA)
ANDA 219864 · ANNORA PHARMA
- 2025MESALAMINEGeneric (ANDA)
ANDA 215269 · NOVITIUM PHARMA
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7645801 | Jul 24, 2027 | in 1 yr 1 mo | SubstanceProduct |

